SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-016015
Filing Date
2024-05-10
Accepted
2024-05-10 16:17:04
Documents
60
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q inbp20240331c_10q.htm   iXBRL 10-Q 1115736
2 EXHIBIT 10.1 FIFTH AMENDMENT TO SENIOR CREDIT FACILITY ex_669398.htm EX-10.1 82462
3 EXHIBIT 10.2 AMENDED AND RESTATED REVOLVING CREDIT NOTE DATED MAY 9 2024 ex_671024.htm EX-10.2 47732
4 EXHIBIT 31.1 CERTIFICATION OF CO-CEOS ex_666622.htm EX-31.1 15662
5 EXHIBIT 31.2 CERTIFICATION OF CFO ex_666623.htm EX-31.2 16556
6 EXHIBIT 32.1 CERTIFICATION OF CO-CEOS PURSUANT TO 906 ex_666624.htm EX-32.1 8548
7 EXHIBIT 32.2 CERTIFICATION OF CFO PURSUANT SECTION 906 ex_666625.htm EX-32.2 7083
  Complete submission text file 0001437749-24-016015.txt   5703683

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA inbp-20240331.xsd EX-101.SCH 44706
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE inbp-20240331_cal.xml EX-101.CAL 39385
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inbp-20240331_def.xml EX-101.DEF 304068
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE inbp-20240331_lab.xml EX-101.LAB 273977
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inbp-20240331_pre.xml EX-101.PRE 327504
64 EXTRACTED XBRL INSTANCE DOCUMENT inbp20240331c_10q_htm.xml XML 983814
Mailing Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Filer) CIK: 0001016504 (see all company filings)

IRS No.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-31668 | Film No.: 24935137
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)